Myelofibrosis: Response to busulfan after hydroxyurea failure

International Journal of Clinical Practice

Volumn 56, Issue 4, 2002, Pages 312-313

  Naqvi, T ^a   Baumann, M A ^a  

^a WRIGHT STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BUSULFAN; CHLORAMBUCIL; HYDROXYUREA;

ADULT; ARTICLE; BONE MARROW SUPPRESSION; CASE REPORT; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG RESPONSE; HUMAN; LEUKEMOGENESIS; MALE; MYELOFIBROSIS; MYELOID METAPLASIA; PRIORITY JOURNAL; THROMBOCYTOPENIA; TREATMENT FAILURE; VASCULITIS;

ALKYLATING AGENTS; ANTIMETABOLITES; BUSULFAN; GASTROINTESTINAL HEMORRHAGE; HUMANS; HYDROXYUREA; MALE; MIDDLE AGED; MYELOFIBROSIS; TREATMENT FAILURE;

EID: 0036285998     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Myelofibrosis with myeloid metaplasia
2. Myelofibrosis with myeloid metaplasia: Diagnositic definition and prognostic classification for clinical studies and treatment guidelines
3. Hydroxyurea-incuded leg ulceration in 14 patients
4. Management of myelofibrosis with intermittent hydroxyurea
5. Reversal of myelofibrosis by hydroxyurea
6. Randomized comparison of busulfan and hydroxyurea in chronic myelogenous leukemia: Prolongation of survival by hydroxyurea
7. 32P alone or in combination with maintenance therapy using hydroxyurea in 461 patients greater than 65 years of age
8. Therapeutic recommendations in polycythemia vera based on polycythemia vera study group protocols
9. Remission of chronic idiopathic myelofibrosis to busulfan treatment
10. Chemotherapy resolves symptoms and reverse marrow fibrosis in myelofibrosis
11. Effect of alkylating agents on hematopoiesis in myelofibrosis: Four case reports
12. Use of testosterone and busulfan in the treatment of myelofibrosis with myeloid metaplasia
13. Alpha-interferon in primary idiopathic myelofibrosis